Showing results (21-30 of 40) with videos related to
Sort By:
Pageof 4
Journal of Combinatorial Chemistry|September 14, 2004
Solid-phase convergent synthesis of a benzimidazolone library via the combination of two smaller arrays of carboxylic acids and secondary aminesIvana Bianchi, Elena La Porta, Daniela Barlocco, et al.Farmaco (Societa Chimica Italiana : 1989)|September 19, 2003
Congo red analogues as potential anti-prion agentsStefania Villa, Giorgio Cignarella, Daniela Barlocco, et al.Current Medicinal Chemistry|June 10, 2016
Iron Acquisition Pathways as Targets for Antitubercular DrugsFiorella Meneghetti, Stefania Villa, Arianna Gelain, et al.Archiv Der Pharmazie|November 17, 2006
3-heptylamino-5-phenylpyridazine derivatives as analogues of Acyl-CoA: cholesterol acyltransferase inhibitors containing the N-heptyl-N'-arylureidic moietyArianna Gelain, Daniela Barlocco, Byong-Mog Kwon, et al.Journal of Medicinal Chemistry|November 24, 2005
Mono- or diphenylpyridazines connected to N-(2,4-difluorophenyl)-N'-heptylurea as acyl-CoA:cholesterol acyltransferase inhibitorsArianna Gelain, Ilaria Bettinelli, Daniela Barlocco, et al.Journal of Medicinal Chemistry|February 21, 2008
Biphenyl versus phenylpyridazine derivatives: the role of the heterocycle in a series of acyl-CoA:cholesterol acyl transferase inhibitorsArianna Gelain, Daniela Barlocco, Byoung-Mog Kwon, et al.Bioorganic & Medicinal Chemistry|March 5, 2003
ortho-Halogen naphthaleins as specific inhibitors of Lactobacillus casei thymidylate synthase. Conformational properties and biological activityStefano Ghelli, Marcella Rinaldi, Daniela Barlocco, et al.Biochimica Et Biophysica Acta|June 27, 2002
Structure-based studies on species-specific inhibition of thymidylate synthaseM Paola Costi, Donatella Tondi, Marcella Rinaldi, et al.Journal of Medicinal Chemistry|August 23, 2002
6-Chloropyridazin-3-yl derivatives active as nicotinic agents: synthesis, binding, and modeling studiesLucio Toma, Paolo Quadrelli, William H Bunnelle, et al.Pharmaceuticals (Basel, Switzerland)|March 6, 2021
Synthesis, Characterization, and Biological Evaluation of New Derivatives Targeting MbtI as Antitubercular AgentsMatteo Mori, Giovanni Stelitano, Laurent R Chiarelli, et al.Pageof 4